Market By Systems, Applications, And Geography | Forecast 2019-2027
According to Triton Market Research, the neurostimulation device market in the Middle East and Africa is expected to grow exponentially at a CAGR of 10.70% for the forecasting period of 2019-2027.
Following are the countries included in the neurostimulation device market analysis of the Middle East and Africa region:
• Saudi Arabia
• Turkey
• The United Arab Emirates
• South Africa
• Rest of MEA
Report scope can be customized per your requirements. Request For Customization
The Middle East and Africa neurostimulation device market is driven by the rise in the number of stroke cases and investments made in research for dementia and Alzheimer’s disease. For instance, according to the Dubai Health Authority (DHA), stroke was the second-leading cause of disability in the UAE in 2016, which is expected to boost the growth of the neurostimulation device market. Moreover, in 2017, the London School of Economics and Political Science had invested significant funds in leading a project that is aimed to build research capacity on dementia care treatments and will also support in developing new devices to treat these diseases. This will fuel the neurostimulation device market in the Middle East and Africa.
In Turkey, it is estimated that the aged population will rise to more than 10% in 2023. As a result, the rate of dementia cases is predicted to increase rapidly. There is the unavailability of required drugs to provide effective treatment for Alzheimer’s disease. Many people are unaware of the disease in the country, which is restraining the market growth.
Medtronic plc is a medical technology and services company that is also the world’s largest medical equipment development company. It manufactures and sells device-based medical therapies. The company offers a wide range of products that include sortable cardiac monitors, implantable defibrillator pacemakers, ablation products, coronary and peripheral stents, electrophysiology catheters, and heart valve replacement technologies.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. MIDDLE
EAST AND AFRICA NEUROSTIMULATION DEVICE MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. PORTER’S
FIVE FORCES MODEL
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTES
2.2.3. BARGAINING
POWER OF SUPPLIERS
2.2.4. BARGAINING
POWER OF BUYERS
2.2.5. THREAT
OF RIVALRY
2.3. VALUE
CHAIN OUTLOOK
2.4. MARKET
TRENDS
2.5. MARKET
SHARE OUTLOOK
2.6. PESTLE
OUTLOOK
2.7. MARKET
ATTRACTIVENESS INDEX
2.8. KEY
INSIGHT
2.9. MARKET
DRIVERS
2.9.1. RISING
INCIDENCE OF NEURO DISEASES
2.9.2. INCREASING
GERIATRIC POPULATION
2.9.3. GROWING
DEMAND FOR MRI SCANS
2.10.
MARKET RESTRAINTS
2.10.1.
HIGH COST OF NEUROMODULATION TREATMENT
2.10.2.
PRESENCE OF ALTERNATIVE THERAPY
2.11.
MARKET OPPORTUNITIES
2.11.1.
HIGH MARKET POTENTIAL FOR SCS DEVICES IN
NEUROSTIMULATION
2.11.2.
TECHNOLOGICAL DEVELOPMENT
2.11.3.
GROWING INCIDENCE OF CHRONIC DISCOMFORT
2.12.
MARKET CHALLENGES
2.12.1.
STRINGENT REGULATORY APPROVALS
2.12.2.
SIDE EFFECTS OF ASSOCIATED NEUROSTIMULATION
DEVICES
3. NEUROSTIMULATION
DEVICE MARKET OUTLOOK – BY SYSTEM
3.1. SPINAL
CORD STIMULATORS (SCS)
3.2. DEEP
BRAIN STIMULATORS (DBS)
3.3. SACRAL
NERVE STIMULATORS (SNS)
3.4. VAGUS
NERVE STIMULATORS (VNS)
3.5. GASTRIC
ELECTRIC STIMULATOR
3.6. OTHER
SYSTEM
4. NEUROSTIMULATION
DEVICE MARKET OUTLOOK – BY APPLICATIONS
4.1. PAIN
MANAGEMENT
4.2. EPILEPSY
4.3. ESSENTIAL
TREMOR
4.4. URINARY
AND FECAL INCONTINENCE
4.5. DEPRESSION
4.6. DYSTONIA
4.7. GASTROPARESIS
4.8. PARKINSON’S
DISEASE
4.9. OTHER
APPLICATIONS
5. NEUROSTIMULATION
DEVICE MARKET – REGIONAL OUTLOOK
5.1.1. COUNTRY
ANALYSIS
5.1.1.1. SAUDI
ARABIA
5.1.1.2. TURKEY
5.1.1.3. UNITED
ARAB EMIRATES
5.1.1.4. SOUTH
AFRICA
5.1.1.5. REST
OF MIDDLE EAST & AFRICA
6. COMPANY
PROFILES
6.1. NEURONETICS,
INC.
6.2. ST.
JUDE MEDICAL, INC. (ACQUIRED BY ABBOTT LABORATORIES)
6.3. HOCOMA
AG
6.4. NEVRO
CORP.
6.5. CYBERONICS
INC.
6.6. COGENTIX
MEDICAL, INC.
6.7. DEPUY
SYNTHES COMPANIES
6.8. DR.
LANGER MEDICAL GMBH
6.9. MEDTRONIC
PLC
6.10.
THE MAGSTIM COMPANY LIMITED
6.11.
ECTRON LIMITED
6.12.
BOSTON SCIENTIFIC CORPORATION
6.13.
EKSO BIONICS HOLDING INC.
6.14.
ALEVA NEUROTHERAPEUTICS SA
6.15.
HELIUS MEDICAL TECHNOLOGIES
7. RESEARCH
METHODOLOGY & SCOPE
7.1. RESEARCH
SCOPE & DELIVERABLES
7.1.1. OBJECTIVES
OF STUDY
7.1.2. SCOPE
OF STUDY
7.2. SOURCES
OF DATA
7.2.1. PRIMARY
DATA SOURCES
7.2.2. SECONDARY
DATA SOURCES
7.3. RESEARCH
METHODOLOGY
7.3.1. EVALUATION
OF PROPOSED MARKET
7.3.2. IDENTIFICATION
OF DATA SOURCES
7.3.3. ASSESSMENT
OF MARKET DETERMINANTS
7.3.4. DATA
COLLECTION
7.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1 MIDDLE EAST AND AFRICA NEUROSTIMULATION DEVICE MARKET
2019-2027 ($ MILLION)
TABLE 2 MIDDLE EAST AND AFRICA NEUROSTIMULATION DEVICE MARKET BY
SYSTEM 2019-2027 ($ MILLION)
TABLE 3 MIDDLE EAST AND AFRICA NEUROSTIMULATION DEVICE MARKET BY
APPLICATIONS 2019-2027 ($ MILLION)
TABLE 4 MIDDLE EAST AND AFRICA NEUROSTIMULATION DEVICE MARKET BY
COUNTRY 2019-2027 ($ MILLION)
FIGURE 1 MIDDLE EAST AND AFRICA NEUROSTIMULATION
DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 2 VALUE CHAIN OUTLOOK
FIGURE 3 NEUROSTIMULATION DEVICE COMPANY MARKET
SHARE OUTLOOK 2018 (%)
FIGURE 4 MIDDLE EAST AND AFRICA NEUROSTIMULATION
DEVICE MARKET BY SPINAL CORD STIMULATORS 2019-2027 ($ MILLION)
FIGURE 5 MIDDLE EAST AND AFRICA NEUROSTIMULATION
DEVICE MARKET BY DEEP BRAIN STIMULATORS 2019-2027 ($ MILLION)
FIGURE 6 MIDDLE EAST AND AFRICA NEUROSTIMULATION
DEVICE MARKET BY SACRAL NERVE STIMULATORS 2019-2027 ($ MILLION)
FIGURE 7 MIDDLE EAST AND AFRICA NEUROSTIMULATION
DEVICE MARKET BY VAGUS NERVE STIMULATORS 2019-2027 ($ MILLION)
FIGURE 8 MIDDLE EAST AND AFRICA NEUROSTIMULATION
DEVICE MARKET BY GASTRIC ELECTRIC STIMULATOR 2019-2027 ($ MILLION)
FIGURE 9 MIDDLE EAST AND AFRICA NEUROSTIMULATION
DEVICE MARKET BY OTHER SYSTEM 2019-2027 ($ MILLION)
FIGURE 10 MIDDLE EAST AND AFRICA NEUROSTIMULATION DEVICE
MARKET BY PAIN MANAGEMENT 2019-2027 ($ MILLION)
FIGURE 11 MIDDLE EAST AND AFRICA NEUROSTIMULATION
DEVICE MARKET BY EPILEPSY 2019-2027 ($ MILLION)
FIGURE 12 MIDDLE EAST AND AFRICA NEUROSTIMULATION
DEVICE MARKET BY ESSENTIAL TREMOR 2019-2027 ($ MILLION)
FIGURE 13 MIDDLE EAST AND AFRICA NEUROSTIMULATION
DEVICE MARKET BY URINARY AND FECAL INCONTINENCE 2019-2027 ($ MILLION)
FIGURE 14 MIDDLE EAST AND AFRICA NEUROSTIMULATION
DEVICE MARKET BY DEPRESSION 2019-2027 ($ MILLION)
FIGURE 15 MIDDLE EAST AND AFRICA NEUROSTIMULATION
DEVICE MARKET BY DYSTONIA 2019-2027 ($ MILLION)
FIGURE 15 MIDDLE EAST AND AFRICA NEUROSTIMULATION
DEVICE MARKET BY GASTROPARESIS 2019-2027 ($ MILLION)
FIGURE 16 MIDDLE EAST AND AFRICA NEUROSTIMULATION
DEVICE MARKET BY PARKINSON’S DISEASE 2019-2027 ($ MILLION)
FIGURE 17 MIDDLE EAST AND AFRICA NEUROSTIMULATION
DEVICE MARKET BY OTHER APPLICATIONS 2019-2027 ($ MILLION)
FIGURE 18 SAUDI ARABIA NEUROSTIMULATION DEVICE MARKET
2019-2027 ($ MILLION)
FIGURE 19 TURKEY NEUROSTIMULATION DEVICE MARKET
2019-2027 ($ MILLION)
FIGURE 20 UNITED ARAB EMIRATES NEUROSTIMULATION DEVICE
MARKET 2019-2027 ($ MILLION)
FIGURE 21 SOUTH AFRICA NEUROSTIMULATION DEVICE MARKET
2019-2027 ($ MILLION)
FIGURE 22 REST OF MIDDLE EAST & AFRICA
NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)